Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...
The market is defying broader economic headwinds through a structural pivot toward high-complexity outsourcing. While general ...
Zacks Investment Research on MSN
Fast-paced momentum stock Century Therapeutics (IPSC) is still trading at a bargain
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that ...
Novoron Bioscience, a San Diego-based biotechnology company developing therapies for neurodegenerative diseases ...
BOCA RATON, FL AND NEVIS, SAINT KITTS & NEVIS / ACCESS Newswire / January 6, 2026 / Empyrean Medical Systems, Inc. ( a leading Florida-based radiation oncology company, and Hamilton Reserve Bank (" ...
Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9 (MMP9) ...
Aspen Neuroscience, Inc., a clinical?stage biotechnology company pioneering autologous regenerative therapies, today announced two executive leadership appointments: Revati Shreeniwas, M.D., FCCP has ...
As spine leaders look ahead to 2026, enthusiasm around regenerative medicine and neuromodulation continues to build. But much of the conversation still flattens a field that is far more complex than ...
At the 22nd Global Cardiovascular Clinical Trialists Forum (CVCT), a leading platform for cardiovascular research, Dr. Eugene Jiaxian Wang, Founder and CEO of HELP Therapeutics, presented China's ...
Study finds fatty diets reprogram liver cells, raising cancer risk Every meal you eat could be quietly shaping your liver’s ...
The much-loved concert production “Somebody Special” is set to return to Claremorris Town Hall Theatre on Saturday, February 28 with tickets now on sale ...
The 5th iPSC Drug Development Summit serves as a pivotal platform for uniting iPSC-based drug developers across the value chain, from research and development through to CMC, to accelerate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback